A citation-based method for searching scientific literature

Ettore Silvagni, Sonia Missiroli, Mariasole Perrone, Simone Patergnani, Caterina Boncompagni, Alessandra Bortoluzzi, Marcello Govoni, Carlotta Giorgi, Stefano Alivernini, Paolo Pinton, Carlo Alberto Scirè. Front Pharmacol 2021
Times Cited: 4







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.
Philip J Mease, Dafna D Gladman, Christopher T Ritchlin, Eric M Ruderman, Serge D Steinfeld, Ernest H S Choy, John T Sharp, Peter A Ory, Renee J Perdok, Mark A Weinberg. Arthritis Rheum 2005
685
50

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
Philip J Mease, Alan J Kivitz, Francis X Burch, Evan L Siegel, Stanley B Cohen, Peter Ory, David Salonen, Joel Rubenstein, John T Sharp, Wayne Tsuji. Arthritis Rheum 2004
689
50

Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.
Dafna D Gladman, Philip J Mease, Christopher T Ritchlin, Ernest H S Choy, John T Sharp, Peter A Ory, Renee J Perdok, Eric H Sasso. Arthritis Rheum 2007
210
50

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu,[...]. Ann Rheum Dis 2020
295
50

Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
Arthur Kavanaugh, Désirée van der Heijde, Iain B McInnes, Philip Mease, Gerald G Krueger, Dafna D Gladman, Juan Gómez-Reino, Kim Papp, Anna Baratelle, Weichun Xu,[...]. Arthritis Rheum 2012
160
50

JAK1 inhibition and inflammatory bowel disease.
Clare Harris, J R Fraser Cummings. Rheumatology (Oxford) 2021
9
25

Selective JAK inhibitors.
Brian W Dymock, Eugene Guorong Yang, Yuyi Chu-Farseeva, Lianbin Yao. Future Med Chem 2014
29
25

SOCS-1 inhibition of type I interferon restrains Staphylococcus aureus skin host defense.
Nathan Klopfenstein, Stephanie L Brandt, Sydney Castellanos, Matthias Gunzer, Amondrea Blackman, C Henrique Serezani. PLoS Pathog 2021
5
25

JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.
Azucena Salas, Cristian Hernandez-Rocha, Marjolijn Duijvestein, William Faubion, Dermot McGovern, Severine Vermeire, Stefania Vetrano, Niels Vande Casteele. Nat Rev Gastroenterol Hepatol 2020
172
25

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.
Inés Roger, Javier Milara, Paula Montero, Julio Cortijo. Int J Mol Sci 2021
12
25

Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.
Alfonso Carotenuto, Luigia Auriemma, Francesco Merlino, Ali Munaim Yousif, Daniela Marasco, Antonio Limatola, Pietro Campiglia, Isabel Gomez-Monterrey, Paolo Santicioli, Stefania Meini,[...]. J Med Chem 2014
19
25

Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
Elvira Favoino, Marcella Prete, Giacomo Catacchio, Piero Ruscitti, Luca Navarini, Roberto Giacomelli, Federico Perosa. Autoimmun Rev 2021
23
25

In Silico Generation of Peptides by Replica Exchange Monte Carlo: Docking-Based Optimization of Maltose-Binding-Protein Ligands.
Anna Russo, Pasqualina Liana Scognamiglio, Rolando Pablo Hong Enriquez, Carlo Santambrogio, Rita Grandori, Daniela Marasco, Antonio Giordano, Giacinto Scoles, Sara Fortuna. PLoS One 2015
21
25

Targeting the JAK/STAT pathway in solid tumors.
Zoya Qureshy, Daniel E Johnson, Jennifer R Grandis. J Cancer Metastasis Treat 2020
37
25

Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses.
Stefania Madonna, Claudia Scarponi, Nunzianna Doti, Teresa Carbone, Andrea Cavani, Pasqualina Liana Scognamiglio, Daniela Marasco, Cristina Albanesi. Eur J Immunol 2013
39
25

SOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis).
Chang He, Cheng-Rong Yu, Mary J Mattapallil, Lin Sun, Joseph Larkin Iii, Charles E Egwuagu. Mediators Inflamm 2016
21
25

Selective and potent proteomimetic inhibitors of intracellular protein-protein interactions.
Anna Barnard, Kérya Long, Heather L Martin, Jennifer A Miles, Thomas A Edwards, Darren C Tomlinson, Andrew Macdonald, Andrew J Wilson. Angew Chem Int Ed Engl 2015
59
25

Anti-inflammatory therapeutics for the treatment of atherosclerosis.
Israel F Charo, Rebecca Taub. Nat Rev Drug Discov 2011
186
25

SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.
Nadia J Kershaw, James M Murphy, Nicholas P D Liau, Leila N Varghese, Artem Laktyushin, Eden L Whitlock, Isabelle S Lucet, Nicos A Nicola, Jeffrey J Babon. Nat Struct Mol Biol 2013
182
25

A Supramolecular Stabilizer of the 14-3-3ζ/ERα Protein-Protein Interaction with a Synergistic Mode of Action.
Alba Gigante, Eline Sijbesma, Pedro A Sánchez-Murcia, Xiaoyu Hu, David Bier, Sandra Bäcker, Shirley Knauer, Federico Gago, Christian Ottmann, Carsten Schmuck. Angew Chem Int Ed Engl 2020
11
25

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.
Srdan Verstovsek, Hagop Kantarjian, Ruben A Mesa, Animesh D Pardanani, Jorge Cortes-Franco, Deborah A Thomas, Zeev Estrov, Jordan S Fridman, Edward C Bradley, Susan Erickson-Viitanen,[...]. N Engl J Med 2010
881
25

Novel activators and small-molecule inhibitors of STAT3 in cancer.
Lehe Yang, Shichong Lin, Lingyuan Xu, Jiayuh Lin, Chengguang Zhao, Xiaoying Huang. Cytokine Growth Factor Rev 2019
57
25

Targeting the Architecture of Deregulated Protein Complexes in Cancer.
Eduard Stefan, Jakob Troppmair, Klaus Bister. Adv Protein Chem Struct Biol 2018
4
25

SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.
Stefania Madonna, Claudia Scarponi, Martina Morelli, Rosanna Sestito, Pasqualina Liana Scognamiglio, Daniela Marasco, Cristina Albanesi. Oncotarget 2017
15
25

Antioxidant Effects of PS5, a Peptidomimetic of Suppressor of Cytokine Signaling 1, in Experimental Atherosclerosis.
Sara La Manna, Laura Lopez-Sanz, Susana Bernal, Luna Jimenez-Castilla, Ignacio Prieto, Giancarlo Morelli, Carmen Gomez-Guerrero, Daniela Marasco. Antioxidants (Basel) 2020
9
25

Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.
Lawrence O Flowers, Howard M Johnson, Mustafa G Mujtaba, Morgan R Ellis, S Mohammed I Haider, Prem S Subramaniam. J Immunol 2004
75
25

Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.
T Shouda, T Yoshida, T Hanada, T Wakioka, M Oishi, K Miyoshi, S Komiya, K Kosai, Y Hanakawa, K Hashimoto,[...]. J Clin Invest 2001
314
25

Cyclic mimetics of kinase-inhibitory region of Suppressors of Cytokine Signaling 1: Progress toward novel anti-inflammatory therapeutics.
Sara La Manna, Laura Lopez-Sanz, Susana Bernal, Sara Fortuna, Flavia A Mercurio, Marilisa Leone, Carmen Gomez-Guerrero, Daniela Marasco. Eur J Med Chem 2021
6
25

Diphenylacetylene-linked peptide strands induce bidirectional β-sheet formation.
Hannah Lingard, Jeongmin T Han, Amber L Thompson, Ivanhoe K H Leung, Richard T W Scott, Sam Thompson, Andrew D Hamilton. Angew Chem Int Ed Engl 2014
29
25

Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Carlota Recio, Ainhoa Oguiza, Iolanda Lazaro, Beñat Mallavia, Jesus Egido, Carmen Gomez-Guerrero. Arterioscler Thromb Vasc Biol 2014
49
25


Peptides as Therapeutic Agents for Inflammatory-Related Diseases.
Sara La Manna, Concetta Di Natale, Daniele Florio, Daniela Marasco. Int J Mol Sci 2018
46
25

Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer.
Sara La Manna, Eunmi Lee, Maria Ouzounova, Concetta Di Natale, Ettore Novellino, Antonello Merlino, Hasan Korkaya, Daniela Marasco. Int J Cancer 2018
18
25

Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes.
Lucas Opazo-Ríos, Yenniffer Sanchez Matus, Raúl R Rodrigues-Díez, Daniel Carpio, Alejandra Droguett, Jesús Egido, Carmen Gomez-Guerrero, Sergio Mezzano. BMJ Open Diabetes Res Care 2020
8
25

A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).
Fabrizio Giordanetto, Romano T Kroemer. Protein Eng 2003
59
25

A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs.
Ji Soo Park, Min Hee Hong, You Jin Chun, Hye Ryun Kim, Byoung Chul Cho. Lung Cancer 2019
18
25

SOCS3 regulates graft-versus-host disease.
Geoffrey R Hill, Rachel D Kuns, Neil C Raffelt, Alistair L J Don, Stuart D Olver, Kate A Markey, Yana A Wilson, Joel Tocker, Warren S Alexander, Andrew D Clouston,[...]. Blood 2010
32
25

Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability.
Jamie J L Williams, Nasser Alotaiq, William Mullen, Richard Burchmore, Libin Liu, George S Baillie, Fred Schaper, Paul F Pilch, Timothy M Palmer. Nat Commun 2018
22
25

From peptides to small molecules: an intriguing but intricated way to new drugs.
P L Scognamiglio, C Di Natale, G Perretta, D Marasco. Curr Med Chem 2013
24
25

The role of SOCS proteins in the development of virus- induced hepatocellular carcinoma.
Jinyan Xie, Mingshu Wang, Anchun Cheng, Renyong Jia, Dekang Zhu, Mafeng Liu, Shun Chen, XinXin Zhao, Qiao Yang, Ying Wu,[...]. Virol J 2021
5
25

SOCS proteins, cytokine signalling and immune regulation.
Akihiko Yoshimura, Tetsuji Naka, Masato Kubo. Nat Rev Immunol 2007
25

Phosphorylation-triggered CUEDC2 degradation promotes UV-induced G1 arrest through APC/C(Cdh1) regulation.
Wei-Na Zhang, Jie Zhou, Tao Zhou, Ai-Ling Li, Na Wang, Jin-Jing Xu, Yan Chang, Jiang-Hong Man, Xin Pan, Tao Li,[...]. Proc Natl Acad Sci U S A 2013
14
25

SOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses.
Shanzhi Huang, Ke Liu, Anchun Cheng, Mingshu Wang, Min Cui, Juan Huang, Dekang Zhu, Shun Chen, Mafeng Liu, Xinxin Zhao,[...]. Front Immunol 2020
28
25

Corrigendum to "Engineered β-hairpin scaffolds from human prion protein regions: Structural and functional investigations of aggregates" [Bioorg. Chem. 96 (2020) 103594].
Concetta Di Natale, Sara La Manna, Concetta Avitabile, Daniele Florio, Giancarlo Morelli, Paolo Antonio Netti, Daniela Marasco. Bioorg Chem 2020
3
33

The molecular basis of JAK/STAT inhibition by SOCS1.
Nicholas P D Liau, Artem Laktyushin, Isabelle S Lucet, James M Murphy, Shenggen Yao, Eden Whitlock, Kimberley Callaghan, Nicos A Nicola, Nadia J Kershaw, Jeffrey J Babon. Nat Commun 2018
164
25

A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation.
Joyce O'Shaughnessy, Angela DeMichele, Cynthia X Ma, Paul Richards, Denise A Yardley, Gail Shaw Wright, Kevin Kalinsky, Ronald Steis, Sami Diab, Gerard Kennealey,[...]. Breast Cancer Res Treat 2018
26
25


Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.
An-Quan Shang, Jian Wu, Feng Bi, Yu-Jie Zhang, Lei-Rong Xu, Ling-Ling Li, Fei-Fei Chen, Wei-Wei Wang, Jian-Jun Zhu, You-Yi Liu. Cancer Biol Ther 2017
33
25

Cucurbitacin-B attenuates CCl4 -induced hepatic fibrosis in mice through inhibition of STAT-3.
Alaliaa M Sallam, Ahmed Esmat, Ashraf B Abdel-Naim. Chem Biol Drug Des 2018
20
25

STAT1 activation regulates proliferation and differentiation of renal progenitors.
Honghe Wang, Yili Yang, Nirmala Sharma, Nadya I Tarasova, Olga A Timofeeva, Robin T Winkler-Pickett, Shunsuke Tanigawa, Alan O Perantoni. Cell Signal 2010
32
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.